Jazz Pharmaceuticals' Lung Cancer Setback: Stock Impact
A late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
Understand what expenses to consider in retirement for effective budgeting. Prepare for a financially sound future!
17,836 articlesA late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
A focused screen uncovers a small group of high-yielding stocks trading double-digit discounts, offering both steady ...
World Cup 2026 in the U.S. has sparked a spending spree among fans who travel with dreams of the tournament, even if ...
A sudden stock pullback creates a rare entry point for patient investors. The company combines non-discretionary serv...
Poet Technologies faces a pivotal year as AI-driven optical interconnects scale. This report analyzes catalysts, risk...
Rising component costs revive a pricing debate for Apple. Analysts weigh whether the company should raise prices on i...
Shareholders allege a controlling investor pressured Red Lobster to endure an endless shrimp push, turning a popular ...
A board director at Veracyte sold shares after a substantial stock run. This guide shows you how to interpret insider...
A downtown Pittsburgh convenience store is at the center of allegations that SNAP benefits were converted to cash and...
Marvell Technology is drawing fresh investor attention as analysts map a path to a $1 trillion market cap by 2032, po...
Axcelis Technologies has seen its stock surge this year, riding AI-chip demand. This guide breaks down what the compa...
A Rotterdam court faces a dramatic move as prosecutors seek bankrupt status for the Knaken exchange after user funds ...